Loading clinical trials...
Loading clinical trials...
A Pilot, Prospective, Open-label Study to Evaluate the Safety and Efficacy of Kaletra® Monotherapy in HIV/HCV Co-infected Subjects.
Conditions
Interventions
Kaletra Tablets
Locations
2
Canada
University of British Columbia
Vancouver, British Columbia, Canada
The Ottawa Hospital, General Campus
Ottawa, Ontario, Canada
Start Date
June 1, 2007
Primary Completion Date
March 1, 2011
Completion Date
April 1, 2011
Last Updated
May 30, 2012
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions